Clinical observation on the combined treatment of 57 cases of non-small cell lung cancer using argon-helium cryosurgery and Chinese herbal medicine.
OBJECTIVE
To observe the clinical effect of the combined therapy using argon-helium cryosurgery (Ar-He knife) and Chinese herbal medicine in treating non-small cell lung cancer (NSCLC).


METHODS
Fifty-seven patients of NSCLC were treated with the combined therapy and observed.


RESULTS
The treatment was successfully completed in all patients with mild adverse reactions. The effective rate was 83.8% 3 months after the operation, 79.6% 6 months after the operation, and 77.3% 12 months after the operation, with median survival of 9 months. The survival rate after 12 months was 46.67% (21/45), 34.62% (9/26) after 18 months, and 36.36% (4/11) after 24 months.


CONCLUSIONS
Argon-helium cryosurgery therapy is superior in its assured orientation, quick tumor load deprivation and less postoperational reaction. Combined with Chinese herbal medication, Argon-helium cryosurgery therapy can prolong survival time, relieve clinical symptoms, and elevate the quality of life in NSCLC patients, and is thus worthy of promotion.
Hu
Kai-wen
KW
Tumor Department, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, 100078, China. kaiwenh@163.com
Li
Quan-wang
QW
Zuo
Ming-huan
MH
Sun
Tao
T
Jiang
Min
M
D000328:Adult; D000368:Aged; D001128:Argon; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery*; D003131:Combined Modality Therapy; D003452:Cryosurgery; D004365:Drugs, Chinese Herbal / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006371:Helium; D006801:Humans; D017567:Karnofsky Performance Status; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D011184:Postoperative Period; D015996:Survival Rate; D016896:Treatment Outcome
D004365:Drugs, Chinese Herbal; D006371:Helium; D001128:Argon